We know that hedge funds generate strong risk-adjusted returns over the long run, therefore imitating the picks that they are collectively bullish on can be a profitable strategy for retail investors. With billions of dollars in assets, smart money investors have to conduct complex analyses, spend many resources and use tools that are not always available for the general crowd. This doesn’t mean that they don’t have occasional colossal losses; they do (like Ackman’s recent Valeant losses). However, it is still good idea to keep an eye on hedge fund activity. With this in mind, as the current round of 13F filings has just ended, let’s examine the smart money sentiment towards Opko Health Inc. (NYSE:OPK) .
Is Opko Health Inc. (NYSE:OPK) a buy, sell, or hold? Money managers are becoming hopeful. The number of long hedge fund positions that are disclosed in regulatory 13F filings went up by 3 recently. OPKwas in 20 hedge funds’ portfolios at the end of September. There were 17 hedge funds in our database with OPK holdings at the end of the previous quarter. At the end of this article we will also compare OPK to other stocks including Axis Capital Holdings Limited (NYSE:AXS), TIM Participacoes SA (ADR) (NYSE:TSU), and Qiagen NV (NASDAQ:QGEN) to get a better sense of its popularity.
At Insider Monkey, we’ve developed an investment strategy that has delivered market-beating returns over the past 12 months. Our strategy identifies the 100 best-performing funds of the previous quarter from among the collection of 700+ successful funds that we track in our database, which we accomplish using our returns methodology. We then study the portfolios of those 100 funds using the latest 13F data to uncover the 30 most popular mid-cap stocks (market caps of between $1 billion and $10 billion) among them to hold until the next filing period. This strategy delivered 18% gains over the past 12 months, more than doubling the 8% returns enjoyed by the S&P 500 ETFs.
How are hedge funds trading Opko Health Inc. (NYSE:OPK)?
At the end of the third quarter, a total of 20 of the hedge funds tracked by Insider Monkey held long positions in this stock, a rise of 18% from the second quarter of 2016. Below, you can check out the change in hedge fund sentiment towards OPK over the last 5 quarters. With hedgies’ capital changing hands, there exists a few noteworthy hedge fund managers who were boosting their stakes considerably (or already accumulated large positions).
According to publicly available hedge fund and institutional investor holdings data compiled by Insider Monkey, Bridger Management, led by Roberto Mignone, holds the biggest position in Opko Health Inc. (NYSE:OPK). Bridger Management has a $16.1 million position in the stock, comprising 1.1% of its 13F portfolio. On Bridger Management’s heels is Jim Simons’ Renaissance Technologies, which holds a $15 million position. Remaining professional money managers with similar optimism comprise Joel Greenblatt’s Gotham Asset Management, and Hal Mintz’s Sabby Capital. We should note that none of these hedge funds are among our list of the 100 best performing hedge funds which is based on the performance of their 13F long positions in non-microcap stocks.